Abstract:OBJECTIVE:To explore the effect of ITF2357, a novel histone deacetylase (HDAC) inhibitor, on the growth, differentiation and apoptosis of acute myeloid leukemic (AML) cells and its mechanism.METHODS:AML cell lines kasumi-1 cells as a model for AML1-ETO positive, and THP1 cells for AML1-ETO negative, the leukemic cells proliferation was analyzed by MTT assay, expression of myeloid-specific differentiation antigen and cell cycle by flow cytometry, cell apoptosis by annexin V staining and flow cytometry. AML1-ETO, acetyl-histone, and caspase protein was analyzed by Western blot.RESULTS:0.5 µmol/L ITF2357 treatment significantly inhibited kasumi-1 cells proliferation, with the 48 h half inhibitory concentration (IC(50)) of 0.1 µmol/L. The initial inhibitory concentration of THP1 cell line was 5 µmol/L. ITF 2357 induced apoptosis of kasumi-1 cells in a time- and dose-dependent manner. A dose-dependent increase in early apoptosis occurred at 24 hours treatment and in late apoptosis at 48 hours treatment by ITF2357. Early apoptosis cells increased from (1.44 ± 1.52)% to (24.51 ± 5.79)%. Late apoptosis cells increased from (2.37 ± 2.8)% to (63.66 ± 1.56)%. ITF2357 induced AML1-ETO degradation by caspase-dependent pathway. 0.25 µmol/L ITF2357 induced a time- and dose-dependent increase in expression of myeloid cell surface protein CD13 and CD15. 5 µmol/L ITF2357 blocked the cells at G(0)/G(1) phase, G(0)/G(1) cells increased from (39.69 ± 6.56)% to (79.2 ± 6.51)% and s-phase cells declined from (60.12 ± 3.29)% to (18.97 ± 6.62)%. Kasumi-1 cells incubated with 0.5 µmol/L of ITF2357, AML1-ETO protein began to decrease at 24 hours and could hardly be detected at 96 hours. ITF2357 induced AML1/ETO degradation through a caspase-dependent mechanism. At the same time, acetylated H3 and H4 increased.CONCLUSION:Low-dose HDAC inhibitor ITF2357 can effectively inhibit the AML cells proliferation, especially for AML1-ETO positive AML cells. It inhibits Kasumi-1 cells proliferation degradation of AML1-ETO protein expression, blocks the cells at G(0)/G(1) phase, and induces apoptosis and differentiation of the cells.

The Apoptosis-Accelerating Effect of Human Recombinant TFAR19 Protein on Leukemia HL-60 Cells

[FTIR Spectroscopy Studies on the Apoptosis-Promoting Effect of TFAR19 on the Erythroleukemia Cell Line MEL].

[Expression of TFAR19 in Apoptotic Processes of Jurkat Cells Induced with Various Methods]

TFAR19, a novel apoptosis-related gene cloned from human leukemia cell line TF-1, could enhance apoptosis of some tumor cells induced by growth factor withdrawal.

[TFAR19 Enhances the Opening of Permeability Transition Pore in the Mitochondrial Membrane of Mice Liver].

Nuclear Translocation of Apoptosis-Related Protein TFAR19 in TF-1 Cells Undergoing Apoptosis

TFAR19 gene changes the biophysical properties of murine erythroleukemia cells

Effect of recombinant TFAR19 protein on telomerase activity and apoptosis of human nasopharyngeal carcinoma CNE-1 cells

Transfer Of Anti-Tfar19 Monoclonal Antibody Into Hela Cells By In Situ Electroporation Can Inhibit The Apoptosis

Effects of TFAR19 Gene on the Growth and Biorheological Properties of Mouse Erythroleukemia Cell Line MEL

Proteinase-Activated Receptor 1 Expression in Human Leukemia Hl-60 Cells and Its Significance.

Effect and Possible Mechanism of Tripterine on Inducing Apoptosis of Human Acute Myelocytic Leukemia HL-60 Cells.

[ITF-2357 on Inhibition Myeloid Leukemic Cell Lines Cells Proliferation in Vitro and Its Mechanism].

Study on the Signal Transduction in Apoptosis of L929 Cell Induced by IFNγ-LTα and LTα

The Basic Research of the Combinatorial Therapy of ABT-199 and Homoharringtonine on Acute Myeloid Leukemia.

Tumor necrosis factor-related apoptosis-inducing ligand gene on human colorectal cancer cell line HT29.

Abnormal Expression of a Novel Apoptosis-Promoting Molecule TFAR19(PDCD5) in the Bone Marrow Cells from Adult Chronic Myeloid Leukemia

Eukaryotic Expression and in Vitro Tumor Cell Apoptosis-induced Effect of Human TRAIL

Effects of TFAR19 gene on the in vivo biorheological properties and pathogenicity of mouse erythroleukemia cell line MEL

Expression of TFRC helps to improve the antineoplastic effect of Ara-C on AML cells through a targeted delivery carrier

Preparation and identification of monoclonal antibodies against human apoptosis-related protein TFAR19]